April 22, 2017 by David Pinto and Chain Drug Review
2017 NACDS Annual Meeting, chain drug industry, chain drug retailers, David Pinto, drug store sales
2017, Issue 04-24-2017, Issues, Opinion

New formats are popping up throughout the chain drug industry, as retailers seek to overcome the sales malaise that has ensnared the industry this year. To recapture lost momentum, chain drug retailers are testing new store sizes, new merchandise assortments, new product locations within stores and new store concepts, sometimes all at once. It’s far
April 3, 2017 by David Pinto and Chain Drug Review
chain drug retailing, chain drug stores, CVS Health, David Pinto, mass retailing industry, pharmacy retailers, Rite Aid, Walgreens Boots Alliance, Walgreens-Rite Aid deal
2017, Issue 04-03-2017, Issues, Opinion

April is here — and still no resolution on the pending acquisition of Rite Aid Corp. by Walgreens Boots Alliance Inc. As time stretches out, this indecision bodes ill for an acquisition that was until recently viewed as an agreement with benefits for both parties. Now, confusion is apparently overtaking certainty — and there is
March 13, 2017 by David Pinto and Chain Drug Review
chain drug retailers, David Pinto, drug store merchandise mix, retail shelf space
2017, Issue 03-13-2017, Issues, Opinion

Once upon a time, the basic drug store merchandise mix was a simple affair, a half-dozen major brands in each product category, a handful of popular sizes, a small assortment of line extensions. No longer. Today’s drug store shelves are crammed with both major and supplementary brands. Indeed, sometimes off-brands dominate. Line extensions sometimes dominate.
February 27, 2017 by David Pinto and Chain Drug Review
chain drug industry, David Pinto, Rite Aid, Rite Aid acquisition, Walgreens Boots Alliance, Walgreens-Rite Aid merger, WBA-Rite Aid deal
2017, Issue 02-27-2017, Issues, Opinion

The major question in mass retailing this year, as the industry concludes the second month of 2017, is when — and indeed whether — Walgreens Boots Alliance’s acquisition of Rite Aid will be fruitfully concluded. As anyone who really cares knows by now the deadline for finalizing the Walgreens-Rite Aid merger has been extended to
January 16, 2017 by David Pinto and Chain Drug Review
Albertsons, America’s drug chains, Bob Miller, CVS Health, David Pinto, Doug McMillon, George Riedl, Helena Foulkes, John Standley, Larry Merlo, Ornella Barra, Rite Aid, Stefano Pessina, Walgreens, Walgreens Boots Alliance, Walmart
2017, Issue 01-16-2017, Issues, Opinion

Going into the new year, several key personnel questions await answers, foremost among them the age-old problem of determining who, in 2017, will emerge as the most influential senior staffers at America’s drug chains. The determination is made more difficult by the fact that, as of this writing, Walgreens’ acquisition of Rite Aid remains unresolved.
January 2, 2017 by David Pinto and Chain Drug Review
Albertsons, chain drug industry, chain drug retailing, CVS, David Pinto, Fred's, mass retailing business, Rite Aid, Target, Walgreens Boots Alliance, Walmart
2017, Issue 01-02-2017, Issues, Opinion

The new year is finally here. On balance, 2016 was a year best forgotten. Very few events of a positive nature will be remembered. On the other hand, many unsettling moments would best be reviewed at another time — if at all. As 2017 dawns, several important questions remain to be resolved, a few of
December 12, 2016 by David Pinto and Chain Drug Review
Affordable Care Act, chain drug industry, chain drug retailers, David Pinto, NACDS, NACDS Week in New York, National Association of Chain Drug Stores
2016, Issue 12-12-2016, Issues, Opinion

For chain drug industry people, 2016 will be remembered as a year best forgotten — as much for the uncertainty of the future as for the problems of the past. As November ended and December began, the National Association of Chain Drug Stores brought industry leaders together in New York City for NACDS Week in
November 21, 2016 by David Pinto and Chain Drug Review
Carmen Bauza, chain drug retailing, CVS, David Pinto, mass retailing, Rite Aid, Walgreens, Walmart
2016, Issue 11-21-2016, Issues, Opinion

As the year nears its end, surprises continue to make news in chain drug retailing. Mostly, negative surprises. Earlier this month, CVS downsized its headquarters staff by some 600 employees, stopping for a moment the retailer’s uninterrupted string of good news. Following that announcement, the Woonsocket, R.I.-based drug chain issued a warning that results might
November 7, 2016 by David Pinto and Chain Drug Review
beauty care category in chain drug stores, beauty care suppliers, chain drug industry, chain drug retailing, David Pinto, National Association of Chain Drug Stores, Target, Total Store Expo, Walmart
2016, Issue 11-07-2016, Issues, Opinion

In chain drug retailing, the most disappointing product category in 2016 has been beauty care. Indeed, the problem with the beauty care category in chain drug stores is, quite simply, the chain drug store’s inability to generate any significant interest in the category. It performs far more credibly in other mass retailing outlets, and it
October 24, 2016 by David Pinto and Chain Drug Review
chain drug industry, chain drug retailers, CVS Pharmacy, David Pinto, drug chains, mass market retailer, mass market retailing, NACDS, NACDS Total Store Expo, Rite Aid, Target, Walgreens, Walmart
2016, Issue 10-24-2016, Issues, Opinion

Two months remain in 2016, and the news out of the chain drug industry remains relatively scanty. Industry gatherings are few and far between — indeed, three months have passed since the NACDS Total Store Expo gathered the industry together in Boston. Against that background, the NACDS year-end meetings, scheduled for New York City following
October 10, 2016 by David Pinto and Chain Drug Review
chain drug industry, chain drug retailing, Cork Walgreen, David Bloom, David Pinto, Shoppers Drug Mart, Walgreens
2016, Issue 10-10-2016, Issues, Opinion

The ranks of the chain drug industry’s giants continue to shrink — and, typically of a business that continues to grow, prosper and change, the tendency is to forget to remember what these icons accomplished. Last month, two executives who were instrumental in building chain drug retailing passed away. They were radically different, yet remarkably
September 26, 2016 by David Pinto and Chain Drug Review
David Pinto, IFPW, International Federation of Pharmaceutical Wholesalers, retail pharmacy industry
2016, Issue 09-26-2016, Issues, Opinion

The International Federation of Pharmaceutical Wholesalers held its 2016 General Membership Meeting in London in mid-September. No one can blame you for not immediately recognizing IFPW. Though it is a global organization with members representing countries around the world, it touches only peripherally on the retail pharmacy industry. Rather, its immediate concern is the intersection
September 12, 2016 by David Pinto and Chain Drug Review
chain drug retailing, Christmas sales, Christmas selling season, David Pinto, holiday selling season
2016, Issue 09-12-2016, Issues, Opinion

The all-important Christmas selling season is about to begin. Truth is, the season begins during the run-up to Halloween and runs, virtually non-stop, through December 24. The highlights are the countdown to the day after Thanksgiving, the period immediately following Thanksgiving week and the final days before Christmas Day. Even now, the nation’s drug stores
August 6, 2016 by David Pinto and Chain Drug Review
chain drug industry, David Pinto, mass retailing, NACDS Total Store Expo
2016, Issue 08-08-2016, Issues, Opinion

The year 2016 is more than half over — and the news concerning the chain drug store community has hardly made a ripple. The Walgreens acquisition of Rite Aid remains a work in progress, though all parties hoped it would have been completed by now. The NACDS Total Store Expo event is unfolding without many